Brief: Creo Medical Expects To Report Growth In Group Revenues Of 13% To £30.8m In FY23

Creo Medical

07/02/2024 07:25

Feb 7 (Reuters) - Creo Medical Group PLC  CREO.L :
    * CREO MEDICAL GROUP  - TRADING UPDATE
    * CREO MEDICAL GROUP PLC - EXPECTS TO REPORT GROWTH IN GROUP
REVENUES OF 13%, FROM £27.2M IN FY22 TO £30.8M IN FY23
    * CREO MEDICAL GROUP PLC - CASH AND CASH EQUIVALENTS AS AT
31
JANUARY 2024 WERE £22.8M (31 DEC 2022: £13.1M)
    * CREO MEDICAL GROUP PLC - REMAINS ON TRACK TO REACH CASH
FLOW
BREAK EVEN AS PLANNED
    * CREO MEDICAL GROUP PLC - FY GROSS MARGIN ACROSS GROUP
IMPROVED
FROM 48.3% TO 49.6% THROUGH SUPPLY CHAIN MANAGEMENT AND
INCREASING SALES VOLUMES
    * CREO MEDICAL GROUP - ANTICIPATES CONTINUED PROGRESS
TOWARDS
SPYDRBLADE'S INTEGRATION INTO ROBOTIC LAPAROSCOPIC TOOLS, DURING
2024

Source text for Eikon:  ID:nRSG2519Ca 
Further company coverage:  CREO.L 

 ((Reuters.Briefs@thomsonreuters.com;))